Latest News and Press Releases
Want to stay updated on the latest news?
-
Innovative FemTech Device Brings UTI and Antenatal Screening into the 21st Century with Unmatched Dignity, Hygiene and Accuracy for Women and Girls
-
BERLIN, May 22, 2025 (GLOBE NEWSWIRE) -- Clue, the data-driven women's health intelligence platform, today announced it has reached 1 million paid subscribers, more than doubling its subscriber base...
-
Analysis of 2.2 million menstrual cycles shows connection between pollution exposure and reproductive health.
-
Clue, the most trusted, data-driven period tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month.
-
Top period tracking app, Clue, has released a survey revealing the top barriers women and people with cycles face when considering cervical screenings.
-
Pune, Oct. 16, 2024 (GLOBE NEWSWIRE) -- FemTech Market Size Analysis: According to SNS Insider, The FemTech Market was valued at USD 55.6 billion in 2023 and is projected to reach USD 125.35...
-
Dublin, Aug. 14, 2024 (GLOBE NEWSWIRE) -- The "Femtech Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Femtech Market was valued at USD 51.80...
-
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "FemTech Market, By Offering, By Application, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for...
-
GAITHERSBURG, MD, May 21, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
-
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...